Type II Secretory Phospholipase A₂ and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization Study

• Lutz P. Breitling ,

  * E-mail: l.breitling@fkfz-heidelberg.de

  Affiliation Division C070 Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯
• Wolfgang Koenig,

  Affiliation Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany

  ⨯
• Marcus Fischer,

  Affiliation Klinik und Poliklinik für Innere Medizin II, University of Regensburg, Regensburg, Germany

  ⨯
• Ziad Mallat,

  Affiliation Division of Cardiovascular Medicine, Addenbrooke's Hospital, Cambridge, United Kingdom

  ⨯
• Christian Hengstenberg,

  Affiliation Klinik und Poliklinik für Innere Medizin II, University of Regensburg, Regensburg, Germany

  ⨯
• Dietrich Rothenbacher,

  Affiliations Division C070 Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany, Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany

  ⨯
• Hermann Brenner

  Affiliation Division C070 Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany

  ⨯